Total reported oral tobacco products segment volume decreased by 3.8% for the third quarter and by 0.5% for the first nine months.
Regarding our decisions around the lockup, we view our ABI stake as a financial investment, and our goal is to maximize the long-term value of the investment for our shareholders.
In the third quarter, Marlboro retail share of the total cigarette category was unchanged, both sequentially and versus the year ago period at 43.2%.
When adjusted for trade inventory movement, calendar differences and other factors, domestic cigarette volumes for the third quarter and first nine months declined by an estimated 7% and 5%, respectively.
Turning to the oral tobacco products segment.
In the third quarter, Altria continued to balance maximizing profitability from our core tobacco businesses with investing to realize a vision of responsibly leading the transition of adult smokers to a smoke-free future.
